Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients

Condition:   Head and Neck Squamous Cell Carcinoma Interventions:   Drug: Toripalimab;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fu Sponsor:   First Affiliated Hospital of Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials